• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session

    11/8/22 12:51:49 PM ET
    $AAON
    $AGRX
    $AKYA
    $ALLK
    Industrial Machinery/Components
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAON alert in real time by email

    Gainers

    • IceCure Medical Ltd (NASDAQ:ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast cancer cryoablation procedures.
    • TaskUs, Inc. (NASDAQ:TASK) shares climbed 37.1% to $21.99 after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
    • Oportun Financial Corporation (NASDAQ:OPRT) gained 36.1% to $5.65 after the company announced upbeat Q3 results.
    • GrowGeneration Corp. (NASDAQ:GRWG) shares climbed 29.9% to $4.30 after the company reported better-than-expected Q3 sales.
    • SkyWater Technology, Inc. (NASDAQ:SKYT) gained 25.8% to $10.87 after the company reported better-than-expected Q3 EPS and sales results.
    • Exela Technologies, Inc. (NASDAQ:XELA) rose 25% to $0.2161.
    • Allakos Inc. (NASDAQ:ALLK) jumped 25% to $7.65 following a narrower-than-expected Q3 loss.
    • Triumph Group, Inc. (NYSE:TGI) surged 23.7% to $11.77 after the company reported upbeat quarterly sales and raised FY23 earnings guidance.
    • Unique Fabricating, Inc. (NYSE:UFAB) surged 23.4% to $0.6480.
    • eHealth, Inc. (NASDAQ:EHTH) gained 22.6% to $3.90 following strong Q3 results.
    • Rover Group, Inc. (NASDAQ:ROVR) jumped 22.3% to $5.04 after the company posted a narrower quarterly loss and issued strong sales forecast.
    • NeoGenomics, Inc. (NASDAQ:NEO) gained 21.5% to $8.63 following better-than-expected Q3 results.
    • Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) jumped 19.3% to $3.9950 following Q3 results.
    • Avalon GloboCare Corp. (NASDAQ:AVCO) rose 19.2% to $0.6695. Avalon Globocare reported a deal to buy 60% interest in Laboratory Services MSO for $31 million in cash and preferred shares.
    • AAON, Inc. (NASDAQ:AAON) gained 19.2% to $78.13 following upbeat Q3 resulst.
    • Hims & Hers Health, Inc. (NYSE:HIMS) rose 19% to $5.50 after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
    • Loyalty Ventures Inc. (NASDAQ:LYLT) jumped 18.6% to $1.7200 following Q3 results.
    • Bit Brother Limited (NASDAQ:BTB) gained 18.1% to $0.1520.
    • SolarEdge Technologies, Inc. (NASDAQ:SEDG) rose 17.7% to $248.77 after the company reported better-than-expected Q3 sales results and issued Q4 sales guidance with a midpoint above analyst estimates..
    • First Advantage Corporation (NASDAQ:FA) gained 17% to $12.14 following Q3 results.
    • Ocuphire Pharma, Inc. (NASDAQ:OCUP) shares rose 16.5% to $2.4350. Ocuphire Pharma entered into a global license agreement for development and commercialization of Nyxol Eye Drops for reversal of mydriasis, presbyopia and night vision disturbances.
    • CTI BioPharma Corp. (NASDAQ:CTIC) rose 16.4% to $5.78 after the company reported better-than-expected Q3 EPS and sales results.
    • Five9, Inc. (NASDAQ:FIVN) gained 16.4% to $54.71 following Q3 results.
    • Veritiv Corporation (NYSE:VRTV) gained 16.1% to $126.27 after the company posted upbeat Q3 results and raised FY22 EPS guidance.
    • Reata Pharmaceuticals, Inc. (NASDAQ:RETA) jumped 16% to $40.51 following Q3 results.
    • Selina Hospitality PLC (NASDAQ:SLNA) gained 15.8% to $4.4966.
    • Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares rose 15% to $2.2083. Canaccord Genuity initiated coverage on Tenaya Therapeutics with a Buy rating and announced a price target of $21.
    • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) gained 14% to $3.3313 after the company reported Q3 financial results.
    • International Game Technology PLC (NYSE:IGT) jumped 13.8% to $22.72. International Game Technology reported third-quarter FY22 revenue growth of 14% year-on-year to $1.06 billion (at constant currency), beating the consensus of $1.01 billion.
    • Lordstown Motors Corp. (NASDAQ:RIDE) rose 12.7% to $2.0840 after the company announced Foxconn will invest up to $170 million in the company.
    • uCloudlink Group Inc. (NASDAQ:UCL) rose 11% to $1.0227 after gaining over 4% on Monday.
    • SunPower Corporation (NASDAQ:SPWR) gained 10.4% to $18.62 after the company reported better-than-expected Q3 EPS and sales results.
    • The Hain Celestial Group, Inc. (NASDAQ:HAIN) rose 10.3% to $20.99 following upbeat quarterly earnings.
    • Planet Fitness, Inc. (NYSE:PLNT) gained 9.5% to $67.60 after the company reported better-than-expected Q3 adjusted EPS and sales results.
    • LivePerson, Inc. (NASDAQ:LPSN) rose 8.9% to $11.02 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.
    • Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) gained 7.7% to $17.95 after the company reported better-than-expected Q3 EPS and sales results and issued Q4 guidance.
    • 2U, Inc. (NASDAQ:TWOU) rose 3.6% to $6.58 after reporting strong Q3 sales. Piper Sandler upgraded 2U from Underweight to Neutral and lowered the price target from $8 to $7.


    Losers

    • NanoString Technologies, Inc. (NASDAQ:NSTG) shares dipped 47.5% to $4.84 after the company reported worse-than-expected Q3 results.
    • Fast Radius, Inc. (NASDAQ:FSRD) dropped 47% to $0.1533 after the company filed voluntary petitions for relief under Chapter 11.
    • Bioventus Inc(NASDAQ:BVS) fell 45.1% to $3.8750 after the company reported downbeat Q3 results and lowered FY22 guidance.
    • R1 RCM Inc. (NASDAQ:RCM) dropped 44.2% to $8.23 after the company reported worse-than-expected Q3 EPS and sales results and cut FY22 revenue guidance below estimates.
    • Unisys Corporation (NYSE:UIS) fell 41.2% to $5.27 following downbeat quarterly sales.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) dipped 40.5% to $1.2850 after dipping 17% on Monday. NeuroBo Pharmaceuticals recently announced pricing of a $30 million underwritten public offering and concurrent private placement.
    • Athersys, Inc. (NASDAQ:ATHX) shares fell 38% to $1.40 after the company reported a proposed public offering.
    • Party City Holdco Inc. (NYSE:PRTY) dipped 38% to $0.9499 after the company reported worse-than-expected Q3 results.
    • Arrival (NASDAQ:ARVL) dropped 36.7% to $0.3755 after the company announced a Q3 business update.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) declined 28% to $4.7650.
    • The Pennant Group, Inc. (NASDAQ:PNTG) fell 27.2% to $9.87 following downbeat quarterly earnings.
    • Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPA) dropped 26% to $0.9349.
    • WM Technology, Inc. (NASDAQ:MAPS) dipped 25.1% to $1.4450 after the company reported worse-than-expected Q3 sales results.
    • Clarus Corporation (NASDAQ:CLAR) dropped 24.9% to $8.27 after the company reported worse-than-expected Q3 results and issued FY22 guidance below estimates.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) fell 24.5% to $1.23 following weak quarterly results.
    • ATI Physical Therapy, Inc. (NASDAQ:ATIP) declined 24.2% to $0.8495 after the company said there is doubt about its ability to continue as a going concern within 12 months following the issuance date of its financial statements for the period ended Sept. 30
    • Tripadvisor, Inc. (NASDAQ:TRIP) shares fell 21.8% to $18.61 after the company reported worse-than-expected Q3 EPS results.
    • Versus Systems Inc. (NASDAQ:VS) dropped 20.6% to $0.1801 after the company announced a 1-for-15 reverse stock split to aid compliance with Nasdaq listing requirements.
    • Lyft, Inc. (NASDAQ:LYFT) shares fell 20.2% to $11.29 after the company reported worse-than-expected Q3 sales results and issued Q4 sales guidance below analyst estimates. Evercore ISI Group downgraded Lyft from Outperform to In-Line and lowered the price target from $41 to $18.
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) dipped 19.8% to $1.3699 after the company filed for an offering of up to 5.6 million shares of common stock.
    • Kaleyra, Inc. (NYSE:KLR) dropped 19.5% to $0.6676 following weak quarterly sales.
    • Akoya Biosciences, Inc. (NASDAQ:AKYA) fell 18.3% to $10.63 as the company posted a wider-than-expected quarterly loss.
    • MeridianLink, Inc. (NYSE:MLNK) fell 17.9% to $13.24 after reporting a loss for the tird quarter.
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) dipped 17.8% to $2.9199 following Q3 loss.
    • Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) dropped 17.8% to $4.61 after the company reported Q3 financial results.
    • Broadmark Realty Capital Inc. (NYSE:BRMK) fell 16.4% to $4.7050 after reporting downbeat quarterly results. The company also named Jeffrey Pyatt as Interim CEO and Jonathan Hermes as Chief Financial Officer.
    • MicroStrategy Incorporated (NASDAQ:MSTR) dropped 14.5% to $228.00 in sympathy with the price of Bitcoin and Ethereum.
    • Silvergate Capital Corporation (NYSE:SI) declined 14.4% to $43.59. Silvergate announced changes to its executive team.
    • Perrigo Company plc (NYSE:PRGO) dropped 14.1% to $33.75 as the company lowered FY22 profit forecast.
    • Lumentum Holdings Inc. (NASDAQ:LITE) fell 13.8% to $60.62 after the company issued Q3 EPS and sales guidance below estimates.
    • Agile Therapeutics, Inc. (NASDAQ:AGRX) fell 13.8% to $0.2749 after the company reported a loss for its third quarter.
    • ChromaDex Corporation (NASDAQ:CDXC) dropped 13.2% to $1.8753.
    • Alto Ingredients, Inc. (NASDAQ:ALTO) fell 12.9% to $3.6150 after the company reported Q3 earnings. The company said results were impacted by logistical constraints, increased transportation costs and low commodity margins.
    • Take-Two Interactive Software, Inc. (NASDAQ:TTWO) fell 12.2% to $95.13 after the company reported worse-than-expected Q2 results and issued weak FY23 guidance.
    • SI-BONE, Inc. (NASDAQ:SIBN) dipped 12.1% to $14.73 following Q3 results.
    • FibroGen, Inc. (NASDAQ:FGEN) fell 11.8% to $14.24 following weak quarterly results.
    • Ramaco Resources, Inc. (NASDAQ:METC) shares fell 11.2% to $11.07 after the company reported worse-than-expected Q3 results.
    • Coinbase Global, Inc. (NASDAQ:COIN) dropped 10.2% to $51.17. Crypto-related stocks dropped sharply amid marked, ongoing volatility in the broader crypto space amid reports of a possible bankruptcy of popular cryptocurrency exchange FTX.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) shares fell 8.6% to $2.14 after dropping over 7% on Monday.
    • DigitalOcean Holdings, Inc. (NASDAQ:DOCN) fell 6.6% to $27.46 after the company issued a weak forecast for the fourth quarter.
    Get the next $AAON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAON
    $AGRX
    $AKYA
    $ALLK

    CompanyDatePrice TargetRatingAnalyst
    SolarEdge Technologies Inc.
    $SEDG
    2/19/2026$38.00 → $43.00Buy
    TD Cowen
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/13/2026$20.00Overweight → Neutral
    Analyst
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/11/2026$23.00Overweight → Equal Weight
    Barclays
    Take-Two Interactive Software Inc.
    $TTWO
    2/10/2026$285.00Outperform → Strong Buy
    Raymond James
    Bioventus Inc.
    $BVS
    2/9/2026$13.00Outperform
    Barrington Research
    DigitalOcean Holdings Inc.
    $DOCN
    2/5/2026$68.00Neutral → Overweight
    Cantor Fitzgerald
    TaskUs Inc.
    $TASK
    2/3/2026$15.00Outperform
    Wedbush
    More analyst ratings

    $AAON
    $AGRX
    $AKYA
    $ALLK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Griffis Sarah sold $183,326 worth of shares (271,032 units at $0.68), decreasing direct ownership by 15% to 1,528,968 units (SEC Form 4)

    4 - WM TECHNOLOGY, INC. (0001779474) (Issuer)

    2/20/26 6:51:00 PM ET
    $MAPS
    Computer Software: Prepackaged Software
    Technology

    GENERAL COUNSEL Camire Brian sold $68,458 worth of shares (101,209 units at $0.68), decreasing direct ownership by 5% to 1,741,653 units (SEC Form 4)

    4 - WM TECHNOLOGY, INC. (0001779474) (Issuer)

    2/20/26 6:49:56 PM ET
    $MAPS
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Francis Douglas sold $69,682 worth of shares (103,019 units at $0.68), decreasing direct ownership by 1% to 8,467,787 units (SEC Form 4)

    4 - WM TECHNOLOGY, INC. (0001779474) (Issuer)

    2/20/26 6:48:09 PM ET
    $MAPS
    Computer Software: Prepackaged Software
    Technology

    $AAON
    $AGRX
    $AKYA
    $ALLK
    SEC Filings

    View All

    SEC Form 144 filed by Tenaya Therapeutics Inc.

    144 - Tenaya Therapeutics, Inc. (0001858848) (Subject)

    2/20/26 5:37:18 PM ET
    $TNYA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 144 filed by Tenaya Therapeutics Inc.

    144 - Tenaya Therapeutics, Inc. (0001858848) (Subject)

    2/20/26 5:35:51 PM ET
    $TNYA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEF 14A filed by SunPower Inc.

    DEF 14A - SunPower Inc. (0001838987) (Filer)

    2/20/26 4:30:43 PM ET
    $SPWR
    Semiconductors
    Technology

    $AAON
    $AGRX
    $AKYA
    $ALLK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Risher John David bought $100,179 worth of shares (7,490 units at $13.38), increasing direct ownership by 0.07% to 11,481,792 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    2/18/26 4:10:21 PM ET
    $LYFT
    Real Estate

    Executive Vice President Wakefield Stephen E bought $484,400 worth of shares (6,141 units at $78.88), increasing direct ownership by 19% to 12,730 units (SEC Form 4)

    4 - AAON, INC. (0000824142) (Issuer)

    12/15/25 4:57:19 PM ET
    $AAON
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Points Jeffrey S. bought $29,632 worth of shares (2,000 units at $14.82), increasing direct ownership by 4% to 54,445 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    12/15/25 4:57:01 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $AAON
    $AGRX
    $AKYA
    $ALLK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for DANYELZA issued to Y-MABS THERAPEUTICS INC

    Submission status for Y-MABS THERAPEUTICS INC's drug DANYELZA (SUPPL-8) with active ingredient NAXITAMAB-GQGK has changed to 'Approval' on 03/20/2024. Application Category: BLA, Application Number: 761171, Application Classification:

    3/21/24 10:20:07 AM ET
    $YMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RYZUMVI issued to OCUPHIRE PHARMA INC

    Submission status for OCUPHIRE PHARMA INC's drug RYZUMVI (ORIG-1) with active ingredient PHENTOLAMINE has changed to 'Approval' on 09/25/2023. Application Category: NDA, Application Number: 217064, Application Classification: Type 3 - New Dosage Form

    9/26/23 12:02:02 PM ET
    $OCUP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    July 13, 2023 - FDA Approves First Nonprescription Daily Oral Contraceptive

    For Immediate Release: July 13, 2023 Today, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily oral contraceptive approved for use in the U.S. without a prescription. Approval of this progestin-only oral contraceptive pill provides an option for consumers to purchase oral contraceptive medicine without a prescription at drug stor

    7/13/23 8:32:15 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAON
    $AGRX
    $AKYA
    $ALLK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ramaco Resources, Inc. to Release Fourth Quarter and Full Year 2025 Financial Results on Wednesday, February 25, 2026 and Host Conference Call and Webcast on Thursday, February 26, 2026

    LEXINGTON, Ky., Feb. 20, 2026 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ:METC, METCB, ", Ramaco", or the ", Company", )) will report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026, after the close of the market. The earnings news release will be available on the Company's investor relations website at www.ramacoresources.com and through major financial information sites. At 9:00 a.m. Eastern Time on Thursday, February 26, 2026, Ramaco Resources will host an investor conference call and webcast where Randall W. Atkins, Chairman and Chief E

    2/20/26 8:00:00 AM ET
    $METC
    $METCB
    Coal Mining
    Energy

    Lyft CFO to Participate in Fireside Chat at the Bernstein TMT Forum

    Lyft, Inc. (NASDAQ:LYFT) announced today that Erin Brewer, Chief Financial Officer, will participate in a fireside chat at the Bernstein Insights: What's Next in Tech? 4th Annual TMT Forum in Palo Alto, CA, on Thursday, February 26, 2026 at 11:00 a.m. PT. A live webcast of the event will be available on the investor relations section of the Lyft website at http://investor.Lyft.com. About Lyft Whether it's an everyday commute or a journey that changes everything, Lyft is driven by our purpose: to serve and connect. Founded in 2012, Lyft has grown into a global mobility platform offering a mix of rideshare, taxis, private hire vehicles, executive chauffeur services, car sharing, bikes,

    2/19/26 4:05:00 PM ET
    $LYFT
    Real Estate

    eHealth Unveils New Growth Strategy Centered on Trusted, Lifelong Customer Relationships

    eHealth's new strategy is expected to drive increased member lifetime value, add new products and services, improve member retention, and build on eHealth's brand recognition AUSTIN, Texas, Feb. 19, 2026 /PRNewswire/ -- eHealth (NASDAQ:EHTH), a leading private online health insurance marketplace, today announced a new company vision focused on supporting Americans with trusted, lifelong guidance on their health coverage, while addressing the divergent needs of Medicare beneficiaries and those who are not yet eligible for Medicare.The new direction strengthens eHealth's ability to help consumers — from their working years, as health status and needs change, and into retirement — match with th

    2/19/26 9:00:00 AM ET
    $EHTH
    Specialty Insurers
    Finance

    $AAON
    $AGRX
    $AKYA
    $ALLK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on SolarEdge Technologies with a new price target

    TD Cowen reiterated coverage of SolarEdge Technologies with a rating of Buy and set a new price target of $43.00 from $38.00 previously

    2/19/26 6:53:08 AM ET
    $SEDG
    Semiconductors
    Technology

    Norwegian Cruise Line downgraded by Analyst with a new price target

    Analyst downgraded Norwegian Cruise Line from Overweight to Neutral and set a new price target of $20.00

    2/13/26 8:29:21 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Coinbase Global downgraded by Monness Crespi & Hardt with a new price target

    Monness Crespi & Hardt downgraded Coinbase Global from Buy to Neutral and set a new price target of $120.00

    2/12/26 7:44:13 AM ET
    $COIN
    Finance: Consumer Services
    Finance

    $AAON
    $AGRX
    $AKYA
    $ALLK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/17/24 5:51:04 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Lyft Inc.

    SC 13G/A - Lyft, Inc. (0001759509) (Subject)

    12/4/24 2:38:58 PM ET
    $LYFT
    Real Estate

    $AAON
    $AGRX
    $AKYA
    $ALLK
    Leadership Updates

    Live Leadership Updates

    View All

    Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

    Eucalyptus is a consumer healthcare leader in Australia, the UK and Germany, with expanding new operations in Japan and Canada. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital health, accelerating the company's ability to bring access to high-quality, personalized care to more people across the world. As its US business continues to grow, Hims & Hers will be well-positioned, upon closing of the acquisition, to expand into Australia and Japan and deepen its presence in the UK, Germany, and Canada. The terms of the transaction have been structu

    2/19/26 6:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    SkyWater Strengthens Commercial Leadership with Appointment of Christine Dunbar

    Veteran Semiconductor Executive to Lead Sales and Solutions Engineering and Drive Growth Across ATS, Wafer Services and Advanced Packaging SkyWater Technology (NASDAQ:SKYT), the largest exclusively U.S.-based pure-play semiconductor foundry, today announced the appointment of Christine Dunbar as senior vice president of sales and solutions engineering, reporting directly to President and COO John Sakamoto. In her role, Dunbar will focus on accelerating customer acquisition and scaling growth across the company's core platforms. She joins as SkyWater continues to build on its commercial momentum and expand its domestic foundry capacity, including its recently acquired 200mm Fab 25 facility

    2/16/26 7:05:00 AM ET
    $SKYT
    Semiconductors
    Technology

    Norwegian Cruise Line Holdings Appoints John W. Chidsey as President and Chief Executive Officer

    MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced that its Board of Directors has appointed John W. Chidsey, a director of NCLH, as President and Chief Executive Officer, effective immediately. Mr. Chidsey succeeds Harry Sommer, who is stepping down as President and Chief Executive Officer and as a Director of NCLH. Mr. Chidsey has a proven track record of leading large global consumer-facing companies through strategic and operational transformation, with experience across franchised operating models, as well as yield-dri

    2/12/26 4:15:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    $AAON
    $AGRX
    $AKYA
    $ALLK
    Financials

    Live finance-specific insights

    View All

    Ramaco Resources, Inc. to Release Fourth Quarter and Full Year 2025 Financial Results on Wednesday, February 25, 2026 and Host Conference Call and Webcast on Thursday, February 26, 2026

    LEXINGTON, Ky., Feb. 20, 2026 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ:METC, METCB, ", Ramaco", or the ", Company", )) will report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026, after the close of the market. The earnings news release will be available on the Company's investor relations website at www.ramacoresources.com and through major financial information sites. At 9:00 a.m. Eastern Time on Thursday, February 26, 2026, Ramaco Resources will host an investor conference call and webcast where Randall W. Atkins, Chairman and Chief E

    2/20/26 8:00:00 AM ET
    $METC
    $METCB
    Coal Mining
    Energy

    Perrigo Announces Quarterly Dividend

    DUBLIN, Feb. 19, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading global provider of consumer products, today announced that its Board of Directors has approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is payable on March 24, 2026, to shareholders of record on March 2, 2026. About Perrigo Perrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pione

    2/19/26 9:00:00 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AAON Announces Fourth Quarter and Full Year 2025 Conference Call and Webcast

    TULSA, Okla., Feb. 18, 2026 /PRNewswire/ -- AAON, Inc. (NASDAQ:  AAON) ("AAON" or the "Company"), a leader in high-performing, energy-efficient HVAC solutions that brings long-term value to customers and owners, announces that it has scheduled its quarterly conference call and webcast for Monday, March 2, 2026, at 9:00 a.m. EST to discuss fourth quarter and full year 2025 financial results.  The results will be released earlier that morning. The conference call will be accessible via dial-in for those who wish to participate in Q&A as well as a listen-only webcast.  The dial-in

    2/18/26 8:00:00 AM ET
    $AAON
    Industrial Machinery/Components
    Industrials